Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008086136> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2008086136 endingPage "S83" @default.
- W2008086136 startingPage "S77" @default.
- W2008086136 abstract "Advantame, a new, high-intensity sweetener that is thought not to be absorbed from the human gastrointestinal tract in appreciable quantities, was evaluated for safety and tolerability in a total of 48 healthy adult volunteers in 2 studies. In the first study 24 subjects were randomized to receive escalating single doses of 0.1, 0.25, or 0.5mg/kg of body weight, and pharmacokinetic and safety parameters were assessed subsequently for 8 days. In the second study, 24 subjects were randomized to receive over 4 weeks either 30 mg advantame/day (split into 3 doses per day), or placebo. All subjects completed both studies and no significant treatment-related adverse effects were observed in any subjects in either study. There were no clinically relevant changes in laboratory parameters, vital signs, electrocardiogram, or physical examination findings. Plasma concentrations of advantame were mostly below the limit of quantification in all samples taken after a single dose or prior to the dose in the repeat-dose study. The concentrations of the hydrolysis product, advantame-acid, were also below the limit of quantification at 12, 36, and 48 h after a single dose of 0.1, 0.25, and 0.5mg/kg body weight, respectively. These studies demonstrate the safety and tolerability of advantame in healthy subjects at doses far exceeding those likely to be encountered in food and beverage use." @default.
- W2008086136 created "2016-06-24" @default.
- W2008086136 creator A5010266198 @default.
- W2008086136 creator A5025025898 @default.
- W2008086136 creator A5073146307 @default.
- W2008086136 creator A5073941344 @default.
- W2008086136 creator A5079849138 @default.
- W2008086136 creator A5082643599 @default.
- W2008086136 creator A5087188663 @default.
- W2008086136 date "2011-11-01" @default.
- W2008086136 modified "2023-10-17" @default.
- W2008086136 title "Acute and multiple-dose studies to determine the safety, tolerability, and pharmacokinetic profile of advantame in healthy volunteers" @default.
- W2008086136 cites W2017099044 @default.
- W2008086136 doi "https://doi.org/10.1016/j.fct.2011.06.043" @default.
- W2008086136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22036029" @default.
- W2008086136 hasPublicationYear "2011" @default.
- W2008086136 type Work @default.
- W2008086136 sameAs 2008086136 @default.
- W2008086136 citedByCount "10" @default.
- W2008086136 countsByYear W20080861362013 @default.
- W2008086136 countsByYear W20080861362014 @default.
- W2008086136 countsByYear W20080861362015 @default.
- W2008086136 countsByYear W20080861362016 @default.
- W2008086136 countsByYear W20080861362017 @default.
- W2008086136 countsByYear W20080861362019 @default.
- W2008086136 countsByYear W20080861362020 @default.
- W2008086136 countsByYear W20080861362021 @default.
- W2008086136 countsByYear W20080861362022 @default.
- W2008086136 countsByYear W20080861362023 @default.
- W2008086136 crossrefType "journal-article" @default.
- W2008086136 hasAuthorship W2008086136A5010266198 @default.
- W2008086136 hasAuthorship W2008086136A5025025898 @default.
- W2008086136 hasAuthorship W2008086136A5073146307 @default.
- W2008086136 hasAuthorship W2008086136A5073941344 @default.
- W2008086136 hasAuthorship W2008086136A5079849138 @default.
- W2008086136 hasAuthorship W2008086136A5082643599 @default.
- W2008086136 hasAuthorship W2008086136A5087188663 @default.
- W2008086136 hasConcept C112705442 @default.
- W2008086136 hasConcept C142724271 @default.
- W2008086136 hasConcept C197934379 @default.
- W2008086136 hasConcept C204787440 @default.
- W2008086136 hasConcept C27081682 @default.
- W2008086136 hasConcept C2778375690 @default.
- W2008086136 hasConcept C71924100 @default.
- W2008086136 hasConcept C98274493 @default.
- W2008086136 hasConceptScore W2008086136C112705442 @default.
- W2008086136 hasConceptScore W2008086136C142724271 @default.
- W2008086136 hasConceptScore W2008086136C197934379 @default.
- W2008086136 hasConceptScore W2008086136C204787440 @default.
- W2008086136 hasConceptScore W2008086136C27081682 @default.
- W2008086136 hasConceptScore W2008086136C2778375690 @default.
- W2008086136 hasConceptScore W2008086136C71924100 @default.
- W2008086136 hasConceptScore W2008086136C98274493 @default.
- W2008086136 hasLocation W20080861361 @default.
- W2008086136 hasLocation W20080861362 @default.
- W2008086136 hasOpenAccess W2008086136 @default.
- W2008086136 hasPrimaryLocation W20080861361 @default.
- W2008086136 hasRelatedWork W1830687917 @default.
- W2008086136 hasRelatedWork W1966047811 @default.
- W2008086136 hasRelatedWork W2003042623 @default.
- W2008086136 hasRelatedWork W202460821 @default.
- W2008086136 hasRelatedWork W2030348591 @default.
- W2008086136 hasRelatedWork W2074207917 @default.
- W2008086136 hasRelatedWork W2147606462 @default.
- W2008086136 hasRelatedWork W2329478898 @default.
- W2008086136 hasRelatedWork W4205587618 @default.
- W2008086136 hasRelatedWork W4366822339 @default.
- W2008086136 hasVolume "49" @default.
- W2008086136 isParatext "false" @default.
- W2008086136 isRetracted "false" @default.
- W2008086136 magId "2008086136" @default.
- W2008086136 workType "article" @default.